Mov Disord Vol 35, Suppl 1 Archives - Page 68 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Patient survey on personal preferences and choices regarding Advance Care Planning(ACP) in Parkinson’s Disease(PD)
M. Khwaja, A. Chatterjee (Reading, United Kingdom)
Objective: Understanding patients' choices and preferences in the advanced stage Parkinson’s disease. Background: Surveys of patients' experiences are increasingly recognized as an essential part of…
MDS Virtual Congress 2020
Efficacy of unilateral thalamotomy by MRgFUS in essential tremor and Parkinson’s disease in a large cohort of patients
M.C Rodríguez Oroz, O. Parras, A. Gorospe, I. Aviles, P. Manrique, L. Gonzalez, J. Guridi (Navarre, Spain)
Objective: To evaluate the efficacy and adverse events of unilateral lesions of the ventral intermediate (VIM) nucleus of the thalamus (thalamotomy) by magnetic resonance guided…
MDS Virtual Congress 2020
Influencing factors when living with Parkinson’s disease: beyond the disease symptomatology
L. Ambrosio, P. Martinez-Martin, C. Rodriguez-Blazquez, M.C Portillo (Pamplona, Spain)
Objective: To identify which are the factors that influence in the process of living with Parkinson's disease (PD). Background: Living with PD is a complex,…
MDS Virtual Congress 2020
Unraveling the role of amylin oligomers in synucleinopathies
I. Martinez Valbuena, R. Valenti Azcarate, C. Caballero, I. Marcilla Garcia, I. Amat-Villegas, J. Sanchez, G. Marti-Andres, L. Armengou, M.R Luquin Piudo (Pamplona, Spain)
Objective: The aim of this work is to elucidate the role of amylin in both alpha-synuclein amyloid formation and Parkinson’s disease (PD) and dementia with…
MDS Virtual Congress 2020
Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms
C.Y Chua, M.E Koh, N.Y Chia, S.E Ng, S.E Saffari, M.C Wen, R.Y Chen, X. Choi, D.L Heng, S.X Neo, K.Y Tay, W.L Au, E.K Tan, L.S Tan, Z. Xu (Singapore, Singapore)
Objective: To determine the prevalence of Subjective Cognitive Complaints (SCC) in early Parkinson’s disease (PD) and examine the correlates between SCC in early PD and…
MDS Virtual Congress 2020
The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions
A. Ivashynka, A. Cucovici (Novara, Italy)
Objective: To evaluate the effect of Deep Brain Stimulation (DBS) on cognitive functions and affective symptoms in patients with Parkinson's Disease (PD). Background: DBS helps…
MDS Virtual Congress 2020
Cerebrospinal fluid protein markers of cognition in early Parkinson’s disease
I. Markaki, S. Bergström, P. Tsitsi, J. Remnestål, A. Månberg, E. Hertz, W. Paslawski, M. Uhlen, G. Mangone, S. Carvalho, O. Rascol, W. Meissner, E. Magnin, U. Wüllner, J.C Corvol, P. Nilsson, P. Svenningsson (Besancon, France)
Objective: The aim of this multicenter study was to investigate potential alterations of CSF protein levels associated with overall and domain-specific cognitive performance in early…
MDS Virtual Congress 2020
Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment
S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)
Objective: To investigate the associations between NBM/Ch4 volume and cortical thickness in PD. Background: Cognitive impairment in Parkinson’s disease (PD) involves the cholinergic system, especially the…
MDS Virtual Congress 2020
Neuroprotective propensity of marmelosin against 6-OHDA-induced cognitive impairment and apoptosis via upregulation of PI3K/Akt pathway
E. Yadav (Allahabad, India)
Objective: Current study was designed to explore the neuroprotective effect of marmelosin against apoptosis caused by 6-hydroxydopamine (6-OHDA) by upregulating phosphoinositide 3-kinase (PI3K)/protein kinase B…
MDS Virtual Congress 2020
A large-scale full GBA1 gene screening in Parkinson’s disease in the Netherlands: 18 novel and 1 ‘Dutch’ variant
J. den Heijer, V. Cullen, M. Quadri, A. Schmitz, D. Hilt, P. Lansbury, H. Berendse, W. de Berg, R. de Bie, J. Boertien, A. Boon, M. Contarino, J. van Hilten, J. Hoff, T. van Mierlo, A. Munts, A. der Plas, M. Ponsen, F. Baas, D. Majoor-Krakauer, V. Bonifati, T. van Laar, G.J Groeneveld (Leiden, Netherlands)
Objective: Assess the entire GBA1 gene in Parkinson’s disease from a single large population. Background: The commonest genetic risk factor for Parkinson’s disease known to…